Inflammatory Medicine Articles & Analysis
9 news found
Restasis and Xiidra work by inhibiting the inflammatory response of DED and stimulating tear production, but these drugs are expensive and accompanied by some unwanted side effects, such as burning and dysgeusia. ...
In the treatment of DED, PDSPs are known to activate the proliferation and differentiation of limbal stem cells which leads to rapid repair of the cornea. They also have anti-inflammatory effects and can maintain the function of goblet cells and meibomian glands to improve tear quality in the long term. ...
An epidural injection is the infusion of robust anti-inflammatory medicine into the area around the spinal cord called the epidural space. ...
Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that Paul Hughes has been appointed as Joint Company Secretary of Mesoblast Limited, joining the existing Company Secretary, Ms Niva Sivakumar. ...
A new study on TIKOMED’s lead drug candidate, ILB®, was published in npj Regenerative Medicine today. The peer-reviewed data from rodent and human disease models showed that ILB® leads to tissue remodelling, reduced fibrosis and functional tissue regeneration – observations indicating the potential of ILB® to alleviate fibrotic diseases. ...
Siolta’s live biotherapeutic product (LBP) platform is designed to develop microbiome-based medicines and diagnostics for the prevention and treatment of chronic diseases in targeted populations. ...
"Siolta Therapeutics brings a unique voice to our coalition due to the company's extensive knowledge of the developing infant gut microbiome and its role in targeted human microbiome therapeutics for the prevention and treatment of inflammatory diseases," said Ken Blount, Ph.D., Chief Scientific Officer of Rebiotix, Inc. and Chairman of MTIG. ...
The Precision Medicine Era Precision medicine holds great promise for improving patient health outcomes. ...
Led by King's College London and also involving the University of Hertfordshire, the Inhalation Translation Challenge aims to help reduce the number of animals used to test medicines for treating inflammatory diseases of the airways such as asthma. Following a successful proof-of-concept study (Phase 1) and a 'Dragons' Den' style interview process, the project ...